Efficacy and safety of antibiotic and invasive management of lung abscess: A systematic review
Abstract
Lung abscess (LA) is a severe, necrotizing infection of the lungs characterized by the formation of one or more cavities within the lung tissue [1]. It commonly develops as a complication of pneumonia, particularly in individuals with pre-existing chronic pulmonary conditions, such as chronic obstructive pulmonary disease (COPD) or in patients with predisposing factors, including alcohol abuse or use of sedative agents [2,3]. Despite advances in medical care, LA remains associated with considerable morbidity and mortality, and evidence to guide optimal treatment remains limited [4].
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Structural and topological analysis of thiosemicarbazone-based metal complexes: computational and experimental study of bacterial biofilm inhibition and antioxidant activity
- Toward better cures for Mycobacterium abscessus lung disease
- Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing
- Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3‐Triazoles: A Computational Docking Techniques
- Upregulation of pmrA, pmrB, pmrC, phoQ, phoP, and arnT genes contributing to resistance to colistin in superbug Klebsiella pneumoniae isolates from human clinical samples in Tehran, Iran
- Whole-genome sequencing of clinical isolates of Citrobacter Europaeus in China carrying blaOXA−48 and blaNDM−1
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.